SUNSHINE BIOPHARMA INC (SBFM) Stock News
NASDAQ:SBFM - Nasdaq - US8677817004 - Common Stock - Currency: USD
SBFM Latest News, Press Relases and Analysis
The market is filled with gapping stocks in Monday's session.
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
What's going on in today's pre-market session
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug
Its subsidiary launched Everolimus — a generic version of Novartis’ Afinitor — in the Canadian generic prescription drug market.
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024
SBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sunshine Biopharma (NASDAQ:SBFM) just reported results for the second quarter o...
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
3 Penny Stocks Ready to Explode Into Dollar Signs by 2028
The best penny stocks to buy are those you can understand and stomach the exceptional risks of in order to profit.
Mentions: MGOL